Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
7MW3711 for injection
DRUG
2 trials
Sponsors
Mabwell (Shanghai) Bioscience Co., Ltd.
Conditions
Advanced Solid Tumor
Phase 1
A Phase 1/2 Study of 7MW3711 in Advanced Solid Tumors
Recruiting
NCT06008366
Mabwell (Shanghai) Bioscience Co., Ltd.
Advanced Solid Tumor
Start: 2023-09-05
End: 2026-02-01
Target: 281
Updated: 2023-09-13
A Study of 7MW3711 in Subjects With Advanced Solid Tumors
Recruiting
NCT06008379
Mabwell (Shanghai) Bioscience Co., Ltd.
Advanced Solid Tumor
Start: 2023-08-28
End: 2026-01-30
Target: 164
Updated: 2023-09-13
Related Papers
Results from a phase 1/2 study of 7MW3711: A novel B7-H3 antibody-drug conjugate (ADC) incorporating a topoisomerase I inhibitor in patients with advanced solid tumors.
Journal of Clinical Oncology
2025-05-28
Results from a phase 1/2 study of 7MW3711: A novel B7-H3 antibody-drug conjugate (ADC) incorporating a topoisomerase I inhibitor in patients with lung cancer.
Journal of Clinical Oncology
2025-05-28